GTBIF
Price
$8.27
Change
+$0.36 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.86B
HKMPY
Price
$46.95
Change
-$1.05 (-2.19%)
Updated
Sep 3 closing price
Capitalization
5.15B
Interact to see
Advertisement

GTBIF vs HKMPY

Header iconGTBIF vs HKMPY Comparison
Open Charts GTBIF vs HKMPYBanner chart's image
Green Thumb Industries
Price$8.27
Change+$0.36 (+4.55%)
Volume$211.33K
Capitalization1.86B
Hikma Pharmaceuticals
Price$46.95
Change-$1.05 (-2.19%)
Volume$420
Capitalization5.15B
GTBIF vs HKMPY Comparison Chart in %
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. HKMPY commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a Hold and HKMPY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (GTBIF: $8.11 vs. HKMPY: $45.87)
Brand notoriety: GTBIF and HKMPY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GTBIF: 25% vs. HKMPY: 255%
Market capitalization -- GTBIF: $1.86B vs. HKMPY: $5.15B
GTBIF [@Pharmaceuticals: Generic] is valued at $1.86B. HKMPY’s [@Pharmaceuticals: Generic] market capitalization is $5.15B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.25B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 1 FA rating(s) are green whileHKMPY’s FA Score has 1 green FA rating(s).

  • GTBIF’s FA Score: 1 green, 4 red.
  • HKMPY’s FA Score: 1 green, 4 red.
According to our system of comparison, GTBIF is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 4 TA indicator(s) are bullish while HKMPY’s TA Score has 4 bullish TA indicator(s).

  • GTBIF’s TA Score: 4 bullish, 5 bearish.
  • HKMPY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both GTBIF and HKMPY are a bad buy in the short-term.

Price Growth

GTBIF (@Pharmaceuticals: Generic) experienced а -6.67% price change this week, while HKMPY (@Pharmaceuticals: Generic) price change was -7.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.81%. For the same industry, the average monthly price growth was +9.99%, and the average quarterly price growth was +86.92%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($5.15B) has a higher market cap than GTBIF($1.86B). GTBIF has higher P/E ratio than HKMPY: GTBIF (73.73) vs HKMPY (13.73). GTBIF YTD gains are higher at: 1.224 vs. HKMPY (-2.983). HKMPY has higher annual earnings (EBITDA): 734M vs. GTBIF (338M). HKMPY has more cash in the bank: 236M vs. GTBIF (177M). GTBIF has less debt than HKMPY: GTBIF (523M) vs HKMPY (1.56B). HKMPY has higher revenues than GTBIF: HKMPY (3.22B) vs GTBIF (1.15B).
GTBIFHKMPYGTBIF / HKMPY
Capitalization1.86B5.15B36%
EBITDA338M734M46%
Gain YTD1.224-2.983-41%
P/E Ratio73.7313.73537%
Revenue1.15B3.22B36%
Total Cash177M236M75%
Total Debt523M1.56B34%
FUNDAMENTALS RATINGS
GTBIF vs HKMPY: Fundamental Ratings
GTBIF
HKMPY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9188
PRICE GROWTH RATING
1..100
4081
P/E GROWTH RATING
1..100
996
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPY's Valuation (10) in the null industry is significantly better than the same rating for GTBIF (85). This means that HKMPY’s stock grew significantly faster than GTBIF’s over the last 12 months.

HKMPY's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that HKMPY’s stock grew similarly to GTBIF’s over the last 12 months.

HKMPY's SMR Rating (88) in the null industry is in the same range as GTBIF (91). This means that HKMPY’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's Price Growth Rating (40) in the null industry is somewhat better than the same rating for HKMPY (81). This means that GTBIF’s stock grew somewhat faster than HKMPY’s over the last 12 months.

GTBIF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for HKMPY (96). This means that GTBIF’s stock grew significantly faster than HKMPY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFHKMPY
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
38%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
55%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
59%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 22 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 7 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
37%
Aroon
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNGAX70.030.53
+0.76%
American Funds New Economy 529A
MTRAX22.130.09
+0.41%
NYLI Income Builder Class A
HIMVX28.760.07
+0.24%
Harbor Mid Cap Value Investor
ALVAX23.85-0.07
-0.29%
American Beacon Large Cap Value A
SBRAX20.47-0.09
-0.44%
Segall Bryant & Hamill All Cap Ret

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+4.55%
CURLF - GTBIF
82%
Closely correlated
+1.79%
TCNNF - GTBIF
82%
Closely correlated
+4.55%
VRNOF - GTBIF
79%
Closely correlated
+5.51%
TSNDF - GTBIF
77%
Closely correlated
+13.08%
CRLBF - GTBIF
71%
Closely correlated
+5.26%
More

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HYPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HYPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
N/A
HYPMY - HKMPY
14%
Poorly correlated
+1.57%
JUSHF - HKMPY
5%
Poorly correlated
+6.59%
HLTRF - HKMPY
4%
Poorly correlated
N/A
INDV - HKMPY
3%
Poorly correlated
+1.01%
GTBIF - HKMPY
2%
Poorly correlated
+4.55%
More